6.
Connor R, Chen B, Choe S, Landau N
. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology. 1995; 206(2):935-44.
DOI: 10.1006/viro.1995.1016.
View
7.
Sanders R, Venturi M, Schiffner L, Kalyanaraman R, Katinger H, Lloyd K
. The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120. J Virol. 2002; 76(14):7293-305.
PMC: 136300.
DOI: 10.1128/jvi.76.14.7293-7305.2002.
View
8.
Parajuli B, Acharya K, Bach H, Parajuli B, Zhang S, Smith 3rd A
. Restricted HIV-1 Env glycan engagement by lectin-reengineered DAVEI protein chimera is sufficient for lytic inactivation of the virus. Biochem J. 2018; 475(5):931-957.
PMC: 5944358.
DOI: 10.1042/BCJ20170662.
View
9.
Gerlits O, Coates L, Woods R, Kovalevsky A
. Mannobiose Binding Induces Changes in Hydrogen Bonding and Protonation States of Acidic Residues in Concanavalin A As Revealed by Neutron Crystallography. Biochemistry. 2017; 56(36):4747-4750.
PMC: 5754002.
DOI: 10.1021/acs.biochem.7b00654.
View
10.
Ang C, Hossain M, Rajpara M, Bach H, Acharya K, Dick A
. Metastable HIV-1 Surface Protein Env Sensitizes Cell Membranes to Transformation and Poration by Dual-Acting Virucidal Entry Inhibitors. Biochemistry. 2020; 59(6):818-828.
PMC: 7362902.
DOI: 10.1021/acs.biochem.9b01008.
View
11.
Lynch R, Boritz E, Coates E, DeZure A, Madden P, Costner P
. Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection. Sci Transl Med. 2015; 7(319):319ra206.
DOI: 10.1126/scitranslmed.aad5752.
View
12.
Barrientos L, Louis J, Ratner D, Seeberger P, Gronenborn A
. Solution structure of a circular-permuted variant of the potent HIV-inactivating protein cyanovirin-N: structural basis for protein stability and oligosaccharide interaction. J Mol Biol. 2002; 325(1):211-23.
DOI: 10.1016/s0022-2836(02)01205-6.
View
13.
Parajuli B, Acharya K, Nangarlia A, Zhang S, Parajuli B, Dick A
. Identification of a glycan cluster in gp120 essential for irreversible HIV-1 lytic inactivation by a lectin-based recombinantly engineered protein conjugate. Biochem J. 2020; 477(21):4263-4280.
DOI: 10.1042/BCJ20200495.
View
14.
Ziolkowska N, Shenoy S, OKeefe B, McMahon J, Palmer K, Dwek R
. Crystallographic, thermodynamic, and molecular modeling studies of the mode of binding of oligosaccharides to the potent antiviral protein griffithsin. Proteins. 2007; 67(3):661-70.
PMC: 7167611.
DOI: 10.1002/prot.21336.
View
15.
Myszka D
. Kinetic, equilibrium, and thermodynamic analysis of macromolecular interactions with BIACORE. Methods Enzymol. 2000; 323:325-40.
DOI: 10.1016/s0076-6879(00)23372-7.
View
16.
McFadden K, Cocklin S, Gopi H, Baxter S, Ajith S, Mahmood N
. A recombinant allosteric lectin antagonist of HIV-1 envelope gp120 interactions. Proteins. 2007; 67(3):617-29.
DOI: 10.1002/prot.21295.
View
17.
Hoque M, Suzuki K, Tsunoda M, Jiang J, Zhang F, Takahashi A
. Structural insights into the specific anti-HIV property of actinohivin: structure of its complex with the α(1-2)mannobiose moiety of gp120. Acta Crystallogr D Biol Crystallogr. 2012; 68(Pt 12):1671-9.
PMC: 3498932.
DOI: 10.1107/S0907444912040498.
View
18.
Barrientos L, Gronenborn A
. The domain-swapped dimer of cyanovirin-N contains two sets of oligosaccharide binding sites in solution. Biochem Biophys Res Commun. 2002; 298(4):598-602.
DOI: 10.1016/s0006-291x(02)02489-0.
View
19.
Yeh J, Seals J, Murphy C, van Halbeek H, Cummings R
. Site-specific N-glycosylation and oligosaccharide structures of recombinant HIV-1 gp120 derived from a baculovirus expression system. Biochemistry. 1993; 32(41):11087-99.
DOI: 10.1021/bi00092a019.
View
20.
Shahzad-Ul-Hussan S, Gustchina E, Ghirlando R, Clore G, Bewley C
. Solution structure of the monovalent lectin microvirin in complex with Man(alpha)(1-2)Man provides a basis for anti-HIV activity with low toxicity. J Biol Chem. 2011; 286(23):20788-96.
PMC: 3121468.
DOI: 10.1074/jbc.M111.232678.
View